Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).

Hare, Joshua M; Bolli, Roberto; Cooke, John P; Gordon, David J; Henry, Timothy D; Perin, Emerson C; March, Keith L; Murphy, Michael P; Pepine, Carl J; Simari, Robert D; Skarlatos, Sonia I; Traverse, Jay H; Willerson, James T; Szady, Anita D; Taylor, Doris A; Vojvodic, Rachel W; Yang, Phillip C; Moyé, Lemuel A

Hare, Joshua M; Bolli, Roberto; Cooke, John P; Gordon, David J; Henry, Timothy D; Perin, Emerson C; March, Keith L; Murphy, Michael P; Pepine, Carl J; Simari, Robert D; Skarlatos, Sonia I; Traverse, Jay H; Willerson, James T; Szady, Anita D; Taylor, Doris A; Vojvodic, Rachel W; Yang, Phillip C; Moyé, Lemuel A.

Affiliation

Hare JM; University of Texas School of Public Health, 1200 Herman Pressler W-848, Houston, TX 77030, USA.

Circulation ; 127(15): 1630-5, 2013 Apr 16.

Article in En | MEDLINE | ID: mdl-23588961

Subject(s)

Clinical Trials, Phase II as Topic/methods; Biomarkers; Cardiovascular Agents/adverse effects; Cardiovascular Agents/therapeutic use; Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/therapy; Clinical Trials, Phase II as Topic/standards; Clinical Trials, Phase II as Topic/statistics & numerical data; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Heart Function Tests; Humans; Multicenter Studies as Topic; Quality of Life; Research Design; Sample Size; Stem Cell Transplantation/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials, Phase II as Topic Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Circulation Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google